Aravax’s PVX108 has received FDA Fast Track designation as the [...]

CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

Fonseca Biosciences has launched XTORO (finafloxacin otic suspension) 0.3% in [...]

China’s National Medical Products Administration has approved Shionogi’s Symproic for [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

MGS has launched the A.i.r. Platform, a new customizable auto-injector [...]

Astoriom, a global quality expert in safeguarding scientific research and [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

The atrial fibrillation (AF) market across the eight major markets [...]

Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]